Two of AstraZeneca’s most important drugs have received a boost, after European regulators backed a pen allowing people to inject themselves with respiratory drug Fasenra, and agreed that ...

AstraZeneca's Fasenra (bevacizumab) is set to challenge GSK’s Nucala (mepolizumab) in eosinophilic granulomatosis with ...

The European Commission (EC) has approved AstraZeneca's Fasenra (benralizumab) as an add-on therapy for adults with relapsing ...

The European Commission has approved the Committee for Medicinal Products for Human Use (CHMP) recommendation to change the terms of marketing authorization for Fasenra (benralizumab). It can now ...

AstraZeneca has gained approval for its Fasenra asthma drug in Europe, while Vertex’s cystic fibrosis drug Orkambi has received an expanded use in children with cystic fibrosis. AZ said Fasenra ...

One area that often gets overlooked is the psychology of product packaging, especially during a rebrand. Navigating the landscape of product development and marketing can be complex. Amidst the ...

New indication supported by the MANDARA trial, which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids AstraZeneca’s Fasenra (benralizumab) ...

for At-Home Use The Fasenra Pen is a prefilled, single-use autoinjector for use as adjunctive maintenance treatment for adults and for children aged 12 years or older who have severe eosinophilic ...

If you click on links we provide, we may receive compensation. Our winner was the Frisco Wire Dog & Small Pet Exercise Pen with Step-Through Door In This Article Our Top Picks People / Jhett ...

AstraZeneca’s (AZN) Fasenra has been approved in the European Union, EU, as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis ...